Skip to content

Therapeutic effect of Bilisoft

Therapeutic effect of Bilisoft - Therapeutic effect of Bilisoft

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000043359
Enrollment
40
Registered
2021-02-17
Start date
2020-09-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonatal jaundic

Interventions

None listed

Sponsors

Haga Red Cross Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Newborn infants indicated for jaundice treatment

Exclusion criteria

Exclusion criteria: Exchange transfusion

Design outcomes

Primary

MeasureTime frame
We compare total bilirubin hourly reduction in before and after phototherapy.

Countries

Japan

Contacts

Public ContactMARIKA ONO

Haga Red Cross Hospital Pediatrics

r1715om@jichi.ac.jp0285843332

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026